PDCD1 and non-Hodgkin lymphoma: Nonetheless, the response rates noted here with nivo/ipi and nivo/liri in B-NHL and T-NHL (Table 3) do not seem appreciably different from each other or from those seen with single-agent PD-1 blockade.